A critical breakthrough in cancer research is arising with the use of nanobodies to re-engage mutated p53. This crucial malignant inhibitor protein is frequently inactivated in various kinds of malignancies, leading https://bookmark-template.com/story30183729/nanobodies-reactivate-p53-new-new-approach-for-cancer-management